Picture

Questions?

+1-866-353-3335

SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: SkyQuest | PRODUCT CODE: 1448236

Cover Image

PUBLISHER: SkyQuest | PRODUCT CODE: 1448236

Global Drug of Abuse Testing Market Size, Share, Growth Analysis, By Drug(Alcohol, Cocaine), By Sample(Urine, Saliva) - Industry Forecast 2024-2031

PUBLISHED:
PAGES: 198 Pages
DELIVERY TIME: 3-5 business days
SELECT AN OPTION
PDF & Excel (Single User License)
USD 5300
PDF & Excel (Multiple User License)
USD 6200
PDF & Excel (Enterprise License)
USD 7100

Add to Cart

Global Drug of Abuse Testing Market size was valued at USD 6.7 Billion in 2022 and is poised to grow from USD 7.12 Billion in 2023 to USD 11.61 Billion by 2031, at a CAGR of 6.3% during the forecast period (2024- 2031).

The global drug of abuse testing market is witnessing significant growth driven by factors such as the increasing prevalence of substance abuse, stringent regulations for drug testing in industries, and growing awareness about drug testing's importance in healthcare and workplace settings. The market is propelled by rising demand for drug testing services to detect and prevent substance abuse, with approximately 255 million users reported in the World Drug Report by the United Nations Office on Drugs and Crime. Government initiatives promoting awareness and organizational compliance for drug testing also contribute to market expansion. However, challenges include the inability of testing products to detect small amounts of certain drugs accurately and the impact of changing laws legalizing recreational or illicit drug use on market demand. Despite challenges, the market offers growth opportunities driven by technological advancements in testing technologies like immunoassays, chromatography, and molecular diagnostics, enhancing testing sensitivity, specificity, and accuracy. Integration of drug testing with other healthcare services and increasing demand for oral fluid testing further drive market growth.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Drug of Abuse Testing Market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Drug of Abuse Testing Market Segmental Analysis

The global drug abuse testing market is segmented on the basis of drug, sample, and region. By drug, the market is segmented into alcohol, cocaine, marijuana/cannabis, LSD, opioids, and others. By sample, the market is segmented into Urine, Saliva, Blood, Hair, Breath, and Others. By region, the market is segmented into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.

Drivers of the Global Drug of Abuse Testing Market

The growing production, consumption, and trade of both new and illicit drugs are expected to drive the demand for Drug of Abuse (DoA) testing, thus fueling the industry's growth. According to the United Nations Office on Drugs and Crime's World Drug Report 2017, there was an annual prevalence of 5.3% for illicit drug use, with 255 million users in 2015. This significant number of drug users underscores the necessity for DoA testing, which will propel the market forward. Government initiatives aimed at raising awareness about drug abuse and increasing organizational compliance for DoA testing will also contribute to the overall growth of the market. Additionally, there is a high demand for testing products that offer enhanced specificity and sensitivity to detect designer drugs, further bolstering the industry's expansion.

Restraints in the Global Drug of Abuse Testing Market

The growth of the drugs of abuse (DOA) testing market may face restraints due to limitations in current testing products detecting small amounts of specific drugs. Additionally, the transformation of laws to legalize recreational or illicit drugs is expected to pose a challenge during the forecast period of 2024-2031. This report on the DOA testing market provides comprehensive information on recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and local market players, emerging revenue opportunities, changes in market regulations, strategic growth analysis, market size, category market growth, application niches, product approvals, product launches, geographic expansions, and technological innovations. For more detailed information on the DOA testing market, you can contact Data Bridge Market Research for an Analyst Brief, where their team will assist you in making informed decisions to achieve market growth.

Market Trends of the Global Drug of Abuse Testing Market

There is a growing trend towards point-of-care testing, which enables quick and convenient drug testing at the bedside or in non-laboratory settings. This trend is fueled by the demand for rapid results and the capability to perform tests in remote or decentralized locations.

Product Code: SQMIG30A2015

Table of Contents

Executive Summary

  • Market Overview
  • Wheel of Fortune

Research Methodology

  • Information Procurement
  • Secondary & Primary Data Sources
  • Market Size Estimation
  • Market Assumptions & Limitations

Parent Market Analysis

  • Market Overview
  • Market Size
  • Market Dynamics
    • Drivers
    • Opportunities
    • Restraints
    • Challenges

Key Market Insights

  • Technology Analysis
  • Pricing Analysis
  • Supply Chain Analysis
  • Value Chain Analysis
  • Ecosystem of the Market
  • IP Analysis
  • Trade Analysis
  • Startup Analysis
  • Raw Material Analysis
  • Innovation Matrix
  • Pipeline Product Analysis
  • Macroeconomic Indicators
  • Top Investment Analysis
  • Key Success Factor
  • Degree of Competition

Market Dynamics & Outlook

  • Market Dynamics
    • Drivers
    • Opportunities
    • Restraints
    • Challenges
  • Regulatory Landscape
  • Porters Analysis
    • Competitive rivalry
    • Threat of Substitute Products
    • Bargaining Power of Buyers
    • Threat of New Entrants
    • Bargaining Power of Suppliers
  • Skyquest Special Insights on Future Disruptions
    • Political Impact
    • Economic Impact
    • Social Impact
    • Technical Impact
    • Environmental Impact
    • Legal Impact

Global Drug of Abuse Testing Market by Drug

  • Market Overview
  • Alcohol
  • Cocaine
  • Marijuana/Cannabis
  • LSD
  • Opioids
  • and Others.

Global Drug of Abuse Testing Market by Sample

  • Market Overview
  • Urine
  • Saliva
  • Blood
  • Hair
  • Breath
  • and Others

Global Drug of Abuse Testing Market Size by Region

  • Market Overview
  • North America
    • USA
    • Canada
  • Europe
    • Germany
    • Spain
    • France
    • UK
    • Rest of Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • South Korea
    • Rest of Asia-Pacific
  • Latin America
    • Brazil
    • Rest of Latin America
  • Middle East & Africa (MEA)
    • GCC Countries
    • South Africa
    • Rest of MEA

Competitive Landscape

  • Top 5 Player Comparison
  • Market Positioning of Key Players, 2021
  • Strategies Adopted by Key Market Players
  • Top Winning Strategies
    • By Development
    • By Company
    • By Year
  • Recent Activities in the Market
  • Key Companies Market Share (%), 2021

Key Company Profiles

  • Abbott Laboratories (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Thermo Fisher Scientific Inc. (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Siemens Healthineers AG (Germany)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • F. Hoffmann-La Roche Ltd (Switzerland)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Alere Inc. (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Quest Diagnostics Incorporated (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Bio-Rad Laboratories, Inc. (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Dragerwerk AG & Co. KGaA (Germany)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Biomerieux SA (France)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Shimadzu Corporation (Japan)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Randox Laboratories Ltd. (United Kingdom)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Psychemedics Corporation (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Sonic Healthcare (Australia)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Merck KGaA (Germany)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • LabCorp (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • MP Biomedicals LLC (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Omega Laboratories, Inc. (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Express Diagnostics International Inc. (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Sciteck, Inc. (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Premier Biotech Inc. (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!